Inflammatix Adds MedTech Veteran as First General Counsel
Inflammatix Raises $57M in Series E Financing
Inflammatix collects $57M as it awaits FDA review of infectious disease test
Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million
